Th17 cells in organ transplantation

  • Ye Chen
  • Kathryn J. Wood
Part of the Progress in Inflammation Research book series (PIR)


A newly discovered subset of T helper cells, Th17 cells, has been implicated in a number of models of autoimmunity. However, their role in transplantation remains undefined. This is despite studies showing a link between IL-17, a cytokine secreted by Th17 cells, and acute allograft rejection. This chapter summarises current evidence for a role of Th17 cells in transplant rejection, tolerance and ischaemia reperfusion injury.


Th17 Cell Experimental Autoimmune Encephalomyelitis Ischaemia Reperfusion Injury Allograft Rejection Delay Graft Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collageninduced arthritis in IL-17-deficient mice. J Immunol 2003; 171: 6173–6177PubMedGoogle Scholar
  2. 2.
    Hirota K, Hashimoto M, Yoshitomi H et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 2007; 204: 41–47PubMedCrossRefGoogle Scholar
  3. 3.
    Sato K, Suematsu A, Okamoto K et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006; 203: 2673–2682PubMedCrossRefGoogle Scholar
  4. 4.
    Cua DJ, Sherlock J, Chen Y et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744–748PubMedCrossRefGoogle Scholar
  5. 5.
    Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133–1141PubMedCrossRefGoogle Scholar
  6. 6.
    Batten M, Li J, Yi S et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006; 7: 929–936PubMedCrossRefGoogle Scholar
  7. 7.
    Korn T, Reddy J, Gao W et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007; 13: 423–431PubMedCrossRefGoogle Scholar
  8. 8.
    Zheng Y, Danilenko DM, Valdez P et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445: 648–651PubMedCrossRefGoogle Scholar
  9. 9.
    Chen X, Vodanovic-Jankovic S, Johnson B, Keller M, Komorowski R, Drobyski WR. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007; 110: 3804–3813PubMedCrossRefGoogle Scholar
  10. 10.
    Witowski J, Ksiazek K, Jorres A. Interleukin-17: A mediator of inflammatory responses. Cell Mol Life Sci 2004; 61: 567–579PubMedCrossRefGoogle Scholar
  11. 11.
    Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 2002; 197: 322–332PubMedCrossRefGoogle Scholar
  12. 12.
    Tang JL, Subbotin VM, Antonysamy MA, Troutt AB, Rao AS, Thomson AW. Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation 2001; 72: 348–350PubMedCrossRefGoogle Scholar
  13. 13.
    Antonysamy MA, Fanslow WC, Fu F et al. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 1999; 162: 577–584PubMedGoogle Scholar
  14. 14.
    Antonysamy MA, Fanslow WC, Fu F et al. Evidence for a role of IL-17 in alloimmunity: A novel IL-17 antagonist promotes heart graft survival. Transplant Proc 1999; 31: 93PubMedCrossRefGoogle Scholar
  15. 15.
    Van Kooten C, Boonstra JG, Paape ME et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 1998; 9: 1526–1534PubMedGoogle Scholar
  16. 16.
    Vanaudenaerde BM, Dupont LJ, Wuyts WA et al. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006; 27: 779–787PubMedCrossRefGoogle Scholar
  17. 17.
    Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25: 821–852PubMedCrossRefGoogle Scholar
  18. 18.
    Miura M, El-Sawy T, Fairchild RL. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma. Am J Pathol 2003; 162: 509–519PubMedGoogle Scholar
  19. 19.
    Verma ND, Boyd R, Robinson C, Plain KM, Tran GT, Hall BM. Interleukin-12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide production. Transplantation 2006; 82: 1324–1333PubMedCrossRefGoogle Scholar
  20. 20.
    Mangan PR, Harrington LE, O’Quinn DB et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441: 231–234PubMedCrossRefGoogle Scholar
  21. 21.
    Kleinschek MA, Owyang AM, Joyce-Shaikh B et al. IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 2007; 204: 161–170PubMedCrossRefGoogle Scholar
  22. 22.
    Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199–210PubMedCrossRefGoogle Scholar
  23. 23.
    Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005; 6: 1219–1227PubMedCrossRefGoogle Scholar
  24. 24.
    Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235–238PubMedCrossRefGoogle Scholar
  25. 25.
    Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179–189PubMedCrossRefGoogle Scholar
  26. 26.
    Xu L, Kitani A, Fuss I, Strober W. Cutting Edge: Regulatory T cells induce CD4+CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 2007; 178: 6725–6729PubMedGoogle Scholar
  27. 27.
    Lohr J, Knoechel B, Wang JJ, Villarino AV, Abbas AK. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 2006; 203: 2785–2791PubMedCrossRefGoogle Scholar
  28. 28.
    Boros P, Bromberg JS. New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant 2006; 6: 652–658PubMedCrossRefGoogle Scholar
  29. 29.
    Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814–1827PubMedCrossRefGoogle Scholar
  30. 30.
    Lemay S, Rabb H, Postler G, Singh AK. Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation 2000; 69: 959–963PubMedCrossRefGoogle Scholar
  31. 31.
    Kwon O, Molitoris BA, Pescovitz M, Kelly KJ. Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. Am J Kidney Dis 2003; 41: 1074–1087PubMedCrossRefGoogle Scholar
  32. 32.
    Patel NS, Chatterjee PK, Di Paola R et al. Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther 2005; 312: 1170–1178PubMedCrossRefGoogle Scholar
  33. 33.
    Kielar ML, John R, Bennett M et al. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 2005; 16: 3315–3325PubMedCrossRefGoogle Scholar
  34. 34.
    Yoshida S, Haque A, Mizobuchi T et al. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 2006; 6: 724–735PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2009

Authors and Affiliations

  • Ye Chen
    • 1
  • Kathryn J. Wood
    • 2
  1. 1.Sir William Dunn School of PathologyUniversity of OxfordOxfordUK
  2. 2.Transplantation Research Immunology Group, Nuffield Department of SurgeryUniversity of OxfordOxfordUK

Personalised recommendations